PMID: 11106831Dec 7, 2000Paper

Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus

Diabetes Research and Clinical Practice
J H NamK B Huh

Abstract

Mutations in the glucokinase (GCK) gene are considered to be a possible cause of maturity-onset diabetes of the young. The purpose of this study was to evaluate the contribution of this gene to the development of post-renal transplantation diabetes mellitus (PTDM). Identification of the GCK mutation was attempted in 58 selected renal allograft recipients with PTDM and 45 normal controls. The exons in the GCK gene were examined using polymerase chain reaction (PCR), followed by an analysis of single-stranded DNA conformational polymorphism (SSCP). The abnormal bands were then confirmed by DNA sequencing analysis. The family members of the patients affected with GCK mutation were also examined. Two of the 58 PTDM patients (3. 4%) were found to have GCK mutations. One had the mutation on exon 5 and the other on intron 7. One control subject had the mutation on intron 9. The mutation on exon 5 was identified as a substitution of CCT (proline) for CTT (leucine) at codon 164, which has never been reported before. The family members of the PTDM patient with a mutation on exon 5 were analyzed by PCR, followed by SSCP, and two of them had the same mutation. The abnormal band seen on SSCP analysis of exon 7 was identified as the C-->T su...Continue Reading

References

Jun 9, 1979·Lancet·D RaumK H Gabbay
Apr 27, 1979·Science·C M AndersonT A Steitz
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Mar 1, 1979·Diabetes Care·J I Rotter, D L Rimoin
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S D HughesC B Newgard
Mar 1, 1992·Diabetes Care·R A DeFronzoE Ferrannini
Aug 10, 1989·The New England Journal of Medicine·J ErikssonLeif Groop
Apr 1, 1980·Transplantation·M G McGeownC M Hill
Mar 11, 1993·The New England Journal of Medicine·P FroguelP Passa

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.